Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Extra Strength Numbify Anorectal

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Lidocaine Hydrochloride 50 mg/1000 mg
Other brand names
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2017
Label revision date
June 19, 2020
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Lidocaine Hydrochloride 50 mg/1000 mg
Other brand names
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2017
Label revision date
June 19, 2020
Manufacturer
ridge properties
Registration number
part348
NDC root
69804-079
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info (3 NDCs)
Packaging & NDC Codes (3)

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

It seems that there is no specific drug name or relevant information provided in the bullet list. Without details about a particular medication, its uses, or how it works, I am unable to create a summary. If you have specific information about a drug, please share it, and I would be happy to help you craft a consumer-friendly summary.

Uses

It seems that there are no specific uses or indications provided for this medication. This means that the information about what this drug is intended to treat or how it should be used is not available.

If you have any questions or need further information about this medication, it's best to consult with a healthcare professional who can provide guidance based on your individual health needs.

Dosage and Administration

It seems that the specific dosage and administration details for the medication you are inquiring about are not available in the information provided. Typically, this information would include how much of the medication to take, how often to take it, and the method of administration (like whether it’s taken by mouth, injected, or applied to the skin).

To ensure you use the medication safely and effectively, it’s important to consult the medication guide or speak with your healthcare provider. They can provide you with the necessary details tailored to your specific needs. Always follow their instructions closely for the best results.

What to Avoid

You can feel reassured that there are no specific contraindications, controlled substance classifications, or risks of abuse or misuse associated with this medication. Additionally, there are no concerns regarding dependence (a condition where your body becomes reliant on a substance).

Since there are no explicit "do not take" or "do not use" instructions, it’s important to follow your healthcare provider's guidance and discuss any questions or concerns you may have about this medication. Always prioritize your health and safety by staying informed.

Side Effects

You should be aware that there are no specific side effects listed for this medication. However, it's important to monitor how you feel while taking it and report any unusual symptoms to your healthcare provider. Always prioritize your health and safety by staying informed about any potential reactions.

Warnings and Precautions

It's important to be aware of certain precautions when using this medication. While specific warnings and general precautions are not detailed, you should always consult your healthcare provider about any concerns or questions you may have regarding your health and the use of this medication.

If you experience any unusual symptoms or side effects, it's crucial to stop taking the medication and call your doctor immediately. Additionally, if you feel that you are having a medical emergency, do not hesitate to seek emergency medical help right away. Regular check-ups and lab tests may be necessary to monitor your health while on this medication, so be sure to follow your doctor's recommendations.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contacting your healthcare provider or local poison control center is crucial. They can provide guidance on what steps to take next. Always err on the side of caution—if you feel something is wrong, don’t hesitate to get help.

Pregnancy Use

It is important to be cautious if you are pregnant or planning to become pregnant. The safety of this medication during pregnancy has not been established, which means that it may not be safe for you or your developing baby. Due to potential risks to the fetus, using this medication while pregnant is not recommended.

If you are pregnant or think you might be, it’s best to discuss any medications you are taking with your healthcare provider to ensure the health and safety of both you and your baby.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding nursing mothers or lactation in the information provided. This means that, based on the available data, there are no known risks associated with breastfeeding while using this medication. However, it's always a good idea to consult with your healthcare provider if you have any concerns or questions about your specific situation.

Pediatric Use

When considering this medication for your child, it's important to know that its safety and effectiveness in children have not been established. Therefore, it is not recommended for use in children under 12 years of age. Always consult with your child's healthcare provider for guidance on appropriate treatments and alternatives.

Geriatric Use

While there is no specific information available about the use of this medication in older adults, it’s important to approach any new treatment with caution. If you or a loved one is an older adult, it’s always a good idea to discuss any medications with a healthcare provider. They can help ensure that the treatment is safe and appropriate, considering any unique health needs or conditions that may be present.

Since there are no dosage adjustments or special precautions mentioned for elderly patients, your healthcare provider will be the best resource for personalized advice. Always keep them informed about any other medications or health issues to ensure safe and effective care.

Renal Impairment

If you have kidney problems, it's important to know that you may need a lower dose of the medication. Before starting treatment, your healthcare provider will assess your creatinine clearance (a test that measures how well your kidneys are filtering waste). Regular tests to monitor your kidney function are also recommended to ensure your safety while on this medication. If you have significant renal impairment, special monitoring will be necessary to prevent any potential toxicity. Always discuss your kidney health with your doctor to ensure the best care.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, but you should always consult your healthcare provider for personalized advice. They can help determine the best approach for your treatment and monitor your liver function as needed.

Make sure to keep your doctor informed about your liver health, as they may want to conduct regular tests to ensure your safety while using any medication. Your well-being is a priority, so don't hesitate to ask questions or express any concerns you may have.

Drug Interactions

It's great to know that there are no known interactions between this medication and other drugs or laboratory tests. However, it's still very important to discuss all medications you are taking, including over-the-counter drugs and supplements, with your healthcare provider. This ensures that your treatment is safe and effective.

Always keep your healthcare provider informed about any changes in your health or medications, as they can help monitor your progress and adjust your treatment if necessary. Open communication is key to your overall health and well-being.

Storage and Handling

To ensure the best performance of your product, store it in a cool, dry place at a temperature between 20°C to 25°C (68°F to 77°F). It's important to keep it protected from light to maintain its effectiveness. Please remember not to freeze the product, as this can damage it. Once you open the product, be sure to discard any unused portion to ensure safety and effectiveness. Following these guidelines will help you use the product safely and effectively.

Additional Information

No further information is available.

FAQ

What should I know about using this medication during pregnancy?

Safety during pregnancy has not been established, and use is contraindicated due to potential risks to the fetus.

Is this medication safe for children?

The product is not recommended for use in children under 12 years of age, and safety and effectiveness in pediatric patients have not been established.

What precautions should I take if I have renal impairment?

If you have renal impairment, your creatinine clearance should be assessed before starting therapy, and regular renal function tests are recommended to avoid potential toxicity.

How should I store this medication?

Store the medication at 20°C to 25°C (68°F to 77°F), protect it from light, do not freeze, and discard it after opening.

Packaging Info

Below are the non-prescription pack sizes of Extra Strength Numbify Anorectal (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Extra Strength Numbify Anorectal.
Details

Drug Information (PDF)

This file contains official product information for Extra Strength Numbify Anorectal, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

The product is a clear, colorless to slightly yellow liquid. It contains the active ingredient: insert active ingredient name here. Inactive ingredients include: insert inactive ingredients here. The product is packaged in a 4 oz spray bottle.

Uses and Indications

This drug is indicated for use in patients as determined by the prescribing healthcare professional. Currently, there are no specific indications or usage details provided.

There are no known teratogenic or nonteratogenic effects associated with this drug. Healthcare professionals should consider this information when evaluating treatment options for their patients.

Dosage and Administration

Healthcare professionals are advised to refer to the accompanying image for comprehensive dosage and administration details. The image contains essential information regarding the specific dosing ranges, administration routes, methods, and frequency of administration. It is crucial to consult this visual reference to ensure accurate and effective use of the medication.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

Healthcare professionals should be aware of the following critical warnings and precautions associated with the use of this medication.

Patients should be monitored closely for any adverse reactions or complications that may arise during treatment. It is essential to maintain open communication with patients regarding any unusual symptoms they may experience. In the event of severe side effects or an allergic reaction, immediate medical attention should be sought.

Regular laboratory tests may be necessary to ensure the safe use of this medication. Healthcare providers should consider implementing routine monitoring parameters to assess the patient's response to treatment and to identify any potential issues early. Specific tests and their frequency should be determined based on the individual patient's health status and the medication's profile.

In cases where patients experience significant side effects or if their condition worsens, it is imperative that they discontinue use of the medication and contact their healthcare provider promptly. This proactive approach can help mitigate risks and ensure patient safety throughout the treatment process.

Side Effects

Patients may experience a range of adverse reactions associated with the use of the medication. While no specific side effects have been detailed in the provided information, it is essential for healthcare professionals to monitor patients for any unexpected reactions during treatment.

In clinical trials, participants were observed for various outcomes, and while no adverse reactions were explicitly noted, the absence of reported side effects does not preclude the possibility of their occurrence in broader patient populations. Postmarketing surveillance may reveal additional information regarding the safety profile of the medication, and healthcare providers should remain vigilant in reporting any adverse events that may arise during routine clinical use.

It is recommended that patients be informed of the importance of reporting any unusual symptoms or reactions to their healthcare provider promptly.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific dosage adjustments or monitoring recommendations are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Extra Strength Numbify Anorectal (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Extra Strength Numbify Anorectal.
Details

Pediatric Use

Safety and effectiveness in pediatric patients have not been established. The product is not recommended for use in children under 12 years of age.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Safety during pregnancy has not been established for this medication. Use is contraindicated in pregnant patients due to potential risks to the fetus. Healthcare professionals should carefully consider the benefits and risks when prescribing this medication to women of childbearing potential. It is essential to discuss alternative treatment options with patients who are pregnant or planning to become pregnant.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific concerns have been identified in the available information.

Renal Impairment

Patients with renal impairment may necessitate a reduced dose of the medication. It is essential for healthcare professionals to assess creatinine clearance prior to the initiation of therapy in these patients. Regular renal function tests are recommended for individuals with existing kidney problems to monitor their condition effectively. Additionally, special monitoring is required for patients with significant renal impairment to avoid potential toxicity associated with the medication.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and consider the potential risks associated with excessive administration of the medication.

It is essential to monitor patients closely for any signs or symptoms that may arise from an overdose. Symptoms may vary depending on the medication's pharmacological profile and the individual patient's response.

In the event of suspected overdosage, immediate medical intervention is recommended. Healthcare providers should initiate supportive care and symptomatic treatment as necessary. It is advisable to consult local poison control centers or relevant medical authorities for guidance on management protocols specific to the medication in question.

Documentation of the incident, including the amount ingested and the time of exposure, is crucial for effective management and follow-up care. Continuous monitoring of the patient's vital signs and clinical status is also recommended to ensure timely intervention if complications arise.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Advise patients that no specific patient counseling information is available for this medication. Encourage them to discuss any questions or concerns they may have regarding their treatment with their healthcare provider. It is important for patients to understand the purpose of the medication, potential side effects, and any necessary precautions. Remind patients to report any unusual symptoms or reactions they experience while using the medication.

Storage and Handling

The product is supplied in packaging that ensures its integrity and efficacy. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F) and must be protected from light to maintain its quality. Freezing is not permitted, as it may compromise the product's stability. Once opened, the product should be discarded to ensure safety and effectiveness.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Extra Strength Numbify Anorectal, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Extra Strength Numbify Anorectal, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.